Paratrophis insignis

Paratrophis insignis · Accepted scientific name

Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆

Paratrophis insignis is a botanical species that has gained scientific interest due to its unique chemical profile. Research focusing on its leaves has identified several bioactive compounds, including beta-sitosterol, moracin M, mulberrofuran U, and ursolic acid. To isolate these constituents, scientists utilize specific preparations such as ethyl acetate-soluble and n-butanol-soluble fractions. These extraction methods allow for a more detailed analysis of the plant's secondary metabolites. Understanding these chemical components is essential for exploring the potential therapeutic properties of this plant.

Quick facts
Synonyms
Morus Insignis · Morus Marmolii · 2 more
Common names
Not available
Family
Moraceae
Distribution
Asia-Temperate
Plant Parts
Leaf

Classification

Common Names

Paratrophis insignis is a botanical species that is widely recognized by its common name, Salvia lechoso. This plant holds a unique place in horticultural discussions due to its distinct characteristics and growth patterns. Identifying it by its common moniker allows gardeners and researchers to communicate more easily about its specific needs. Understanding the relationship between its scientific designation and its popular name is essential for accurate cultivation. Consequently, mastering these naming conventions ensures that enthusiasts can care for the species effectively.

Sources: Catalogue of Life (COL)

Synonyms

Paratrophis insignis is a species characterized by a complex taxonomic history involving several different botanical names. Throughout various scientific studies, it has been identified under the synonym Morus insignis. The plant's classification has also been linked to the name Morus marmolii in certain botanical records. Furthermore, researchers have previously cataloged this species as Morus peruviana. Finally, the name Morus trianae serves as another recognized synonym within its diverse nomenclature.

Sources: The World Checklist of Vascular Plants (WCVP)

Taxonomy

Paratrophis insignis is a distinctive botanical specimen belonging to the kingdom Plantae. Within this vast biological kingdom, the plant is classified under the class Equisetopsida. It falls specifically into the order Rosales, showcasing its evolutionary connections to related species. Furthermore, this plant is a member of the family Moraceae, a group known for its diverse characteristics. Ultimately, it is identified by its unique scientific designation within the genus Paratrophis.

Rank Classification
Kingdom Plantae
Phylum Streptophyta
Class Equisetopsida
Subclass Magnoliidae
Order Rosales
Family Moraceae
Genus Paratrophis

Sources: The World Checklist of Vascular Plants (WCVP)

Distribution

Geographic Regions

Paratrophis insignis maintains an extensive geographic range that spans across a vast portion of the Western Hemisphere. Its distribution begins in North America and extends through various regions of Mexico, including the southeastern territories. The species continues its journey southward into Central America, where it can be found throughout Costa Rica, Guatemala, and Panamá. Moving further into the southern reaches of the continent, its presence is also well-documented across Northern South America. Specifically, this wide-ranging plant establishes itself within the diverse landscapes of Venezuela.

Sources: The World Checklist of Vascular Plants (WCVP)

Identification

Biological Activities

Compounds

Paratrophis insignis, also known as Morus insignis, serves as a rich source of various bioactive chemical compounds. Research into its leaf fractions has revealed the presence of several significant constituents, including moracin M and mulberrofuran U. Additionally, the plant contains notable sterols such as beta-sitosterol and beta-sitosterol-3-O-beta-glucopyranoside. The chemical profile is further enriched by the presence of ursolic acid within its soluble fractions. These diverse compounds contribute to the plant's documented hypoglycemic activity in experimental models.

Conditions

Paratrophis insignis, specifically through its leaves, exhibits significant hypoglycemic activity when applied to streptozotocin (STZ)-induced hyperglycemic rats. Research indicates that the ethyl acetate- and n-butanol-soluble fractions of this plant are responsible for managing these elevated blood glucose levels. Within these active fractions, scientists isolated two new 2-arylbenzofuran derivatives known as mulberrofuran U and moracin M-3-O-beta-D-glucopyranoside. These novel compounds were identified alongside several known substances, including beta-sitosterol and ursolic acid, through various spectroscopic methods. The study effectively demonstrates how the chemical constituents of the plant serve to treat the hyperglycemic condition in the model rats.

Preparations

Paratrophis insignis is prepared as ethyl acetate-soluble fractions to investigate its chemical properties. These specific ethyl acetate-soluble fractions are extracted from the plant material for further analysis. Additionally, Paratrophis insignis is prepared as n-butanol-soluble fractions during the study. Both of these distinct fractionation methods are utilized to isolate bioactive components. The preparation of these various soluble fractions serves as a crucial step in identifying the plant's specific compounds.

Parts used

Paratrophis insignis contains specific botanical components that are essential for scientific study, particularly its leaves. Research into these leaf fractions has revealed significant hypoglycemic activity when tested on streptozotocin-induced hyperglycemic rats. Through the extraction of ethyl acetate and n-butanol-soluble fractions, scientists have been able to isolate various bioactive compounds. This process led to the discovery of two new 2-arylbenzofuran derivatives, specifically mulberrofuran U and moracin M-3-O-beta-D-glucopyranoside. These findings highlight the chemical complexity found within the plant's foliage and its potential medicinal applications.